USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bioinfra Life Science Inc.

USPTO PatentsView assignee record - 5 granted patents across 12 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

11.6

Avg claims per patent

5-year filing velocity

The verdict

Bioinfra holds 5 US patents across 12 technology areas, rank #45,291 of 50,000 tracked assignees.

#45,291
of 50,000 US assignees by volume: Top 23%
by Innovation Score (45.4/100): 11.6
avg claims per patent

Portfolio overview

Bioinfra Life Science Inc. has been granted 5 US utility patents between 2020 and 2025, placing Bioinfra Life Science Inc. at rank #45,291 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.6 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Bioinfra Life Science Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Bioinfra sits between Bio2electric, Llc (5 patents, rank #45,287) and Biotherm Hydronic, Inc. (5 patents, rank #45,295) - the closest US assignees by grant volume. The composite Innovation Score of 45.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Bioinfra Life Science Inc.'s 11.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bioinfra Life Science Inc. against peers pursuing similar technology classes.

Bio2electric

5
Biocheminsights

5
Bioflex Solutions

5
Biogenex Laborato…

5
Bioprotect

5
Bioq Pharma Incor…

5
Bioshift

5
Biotherm Hydronic

5
Bioinfra Life Sci… ◀

5

What this shows Bioinfra holds 5 patents at rank #45,291, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bioinfra

By rank, the assignees closest to #45,291 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Bioinfra's primary technology class.

Bioinfra's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Bioinfra Life Science Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	20.0%
2022	2	40.0%
2024	1	20.0%
2025	1	20.0%

Which technologies does Bioinfra Life Science Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

G06F - ELECTRIC DIGITAL DATA PROCESSING 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 1

G06N - COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS 1

H04L - TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION 1

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 1

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 1

Top 12 of 12 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Simple

Where it ranks

Overall rank by patents

#45,291

Across all tracked assignees

Innovation Score

45.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Bioinfra Life Science Inc. hold?

Bioinfra Life Science Inc. holds 5 US granted patents filed between 2020 and 2025, spanning 12 technology areas.

What is Bioinfra Life Science Inc.'s Innovation Score?

Bioinfra Life Science Inc. has an Innovation Score of 45.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bioinfra Life Science Inc. focus on?

Bioinfra Life Science Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 2 patents. The company has filed patents in 12 CPC subclasses total.

Is Bioinfra Life Science Inc.'s patent filing rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Bioinfra Life Science Inc..

What does claim depth mean for Bioinfra Life Science Inc.'s patents?

Bioinfra Life Science Inc.'s patents average 11.6 claims each. This is relatively simple claim structure, typical for focused inventions.

How is the Bioinfra Life Science Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Bioinfra's 5 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Bioinfra ranks #45,291 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.